Hirschsprung's Disease - Nursing Diagnosis and Interventions

Hirschsprung's Disease - Nursing Diagnosis and Interventions

Hirschsprung's disease is a blockage of the large intestine due to improper muscle movement in the bowel. It is a congenital condition, which means it is present from birth.
Symptoms that may be present in newborns and infants include:
  • Difficulty with bowel movements

  • Failure to pass meconium shortly after birth

  • Failure to pass a first stool within 24 - 48 hours after birth

  • Infrequent but explosive stools

  • Jaundice

  • Poor feeding

  • Poor weight gain

  • Vomiting

  • Watery diarrhea (in the newborn)

Symptoms in older children:
  • Constipation that gradually gets worse

  • Fecal impaction

  • Malnutrition

  • Slow growth

  • Swollen belly

It is diagnosed by taking a small piece of tissue from the bowel to examine under a microscope. This is called a rectal biopsy. If the piece of tissue does not have any ganglion cells, this means Hirschsprung’s disease has been diagnosed.

Nursing Diagnosis and Interventions for Hirschsprung's Disease
1. Constipation related to obstruction
The inability of the colon to evacuate stool (Wong, Donna, 2004: 508)
Goal: Children can perform elimination with some adaptations to function normally and eliminations can be done.
Expected outcomes:
  • Patients can perform elimination with some adaptation.

  • There is an increased elimination pattern better.

Intervention:
  • Provide assistance enema with 0.9% NaCl physiological fluids.

  • Observation of vital signs and bowel every 2 hours.

  • Observation expenditure per rectal stool: form, consistency, amount.

  • Observations affecting intake patterns and stool consistency.

  • Recommended for the diet that has been recommended.

2. Imbalanced Nutrition, Less Than Body Requirements related to the digestive tract, nausea and vomiting
Goal: The patient receives adequate nutrition in accordance with the recommended diet.
Expected outcomes:
  • Weight loss patients according to age.

  • Patient's skin turgor moist.

  • Parents can choose the recommended foods.

Intervention
  • Provide adequate nutrition in accordance with the recommended diet.

  • Measure the child's body weight per day.

  • Use alternate routes nutrition (such as NGT and parenteral) for those patients who had started to feel nauseous and vomiting.

3. Risk for Fluid Volume Deficit related to intake less (Betz, Cecily & Sowden 2002:197)
Goal: hydration status of patients can meet the body's needs.
Expected outcomes:
  • Moist skin turgor.

  • Fluid balance.

Intervention
  • Provide adequate fluid intake in patients.

  • Monitor signs turgor adequate body fluids, intake - output.

  • Observation of increased nausea and vomiting, anticipated deficit of body fluids immediately.

4. Knowledge Deficit: about the disease process and treatment.
Goal: patients' knowledge about the disease to be more adequate
Expected outcomes:
  • Knowledge of the patient and family about the disease, treatments and medications increased.

Intervention:
  • Give a chance to the patient's family to ask for the things he wants to know in relation to the disease being treated.

  • Assess family knowledge about Mega Colon.

  • Assess family background.

  • Explain about the disease process, diet, treatments, and medicines to the patient's family.

  • Explain all the procedures that will be implemented and the benefits for patients.

1 Response to "Hirschsprung's Disease - Nursing Diagnosis and Interventions"

  1. I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
    liver already present. I started on antiviral medications which
    reduced the viral load initially. After a couple of years the virus
    became resistant. I started on HEPATITIS B Herbal treatment from
    ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
    treatment totally reversed the virus. I did another blood test after
    the 6 months long treatment and tested negative to the virus. Amazing
    treatment! This treatment is a breakthrough for all HBV carriers.

    BalasHapus